Health in Liberia 1,232 indicators covering health for Liberia. IndicatorLatest Year10-yr change Rank Mortality caused by road traffic injury 38.9 per 100,000 population 2019 up 16.5% 4th Mortality caused by road traffic injury, female 24.9 per 100,000 female population 2019 up 8.7% 1st Mortality caused by road traffic injury, male 52.7 per 100,000 male population 2019 up 20.0% 7th Ipv vaccine coverage 82 2024 up 182.8% 145th Deaths in armed conflicts by country, annual growth rate -100 % change on previous year 2004 down 278.7% 33rd Deaths in armed conflicts by region, annual growth rate -100 % change on previous year 2004 down 278.7% 33rd Tb patients living with hiv receiving art 705 2021 up 1,578.6% 40th HIV-positive TB patients on ART (antiretroviral therapy) 87.0% 2024 up 210.7% 102nd Hospital beds 15.9 2021 up 98.8% 106th Treatment success rate for patients treated for MDR-TB 59.0% 2022 up 195.0% 125th New leprosy case detection rate per 1 000 000 population 11.22 2024 down 86.1% 44th Treatment success rate: HIV-positive TB cases 68 2022 down 5.6% 91st Prevalence of wasting, weight for height 3.4% 2019 down 20.9% 59th Estimated number of children (aged 0-17 years) who have lost one or 230,000 2024 up 21.1% 63rd Weight-for-height <-2 SD 3.4 2019 down 21.0% 59th Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 0.0% 2025 — 167th International Health Regulations core capacity scores, SPAR version 30 2025 — 139th Prevalence of underweight, weight for age 10.9% 2019 down 33.5% 45th Leprosy registered prevalence rate per 1 000 000 population 11.22 2024 down 90.6% 45th Leprosy - Number of new leprosy cases among children 1 2024 down 98.0% 59th Leprosy - Number of cases registered for treatment 63 2024 down 88.0% 57th New leprosy child case detection rate (less than 15 years of age) per 0.451 2024 down 98.3% 54th Children (0-14) living with HIV 3,700 2024 down 49.3% 37th Ipv1 number unvaccinated 28,146 2023 down 73.3% 68th Children living with hiv 3,700 2024 down 49.3% 37th Number of reported cases of poliomyelitis by wild poliovirus 0 2023 — 3rd Age-standardized prevalence of current tobacco use among persons aged 5.2% 2024 down 37.3% 150th Number of female leprosy new cases 21 2024 down 87.6% 54th Estimated number of malaria deaths 3,563 2024 up 8.1% 26th Estimated number of malaria cases 967,319 2024 down 26.3% 34th National smoking ban: NUMBER OF PLACES SMOKE-FREE 0 2022 — 157th Number of prevalent tuberculosis cases 22,000 2014 up 69.2% 54th Estimated malaria incidence 172.34 2024 down 40.1% 27th Estimated malaria mortality rate 63.48 2024 down 12.1% 10th Number of new G2D leprosy cases 18 2024 up 260.0% 41st Leprosy - New leprosy cases with G2D rate per 1 000 000 population 3.21 2024 up 181.6% 20th 3.7.2 Adolescent birth rate per 1,000 women 128 2018 down 15.0% 11th Proportion of total government spending on essential services, health 10.2% 2013 up 90.5% 67th Inflation-adjusted prices for most sold brand of cigarettes: Prices 4.16 2022 up 107.0% 127th Taxes as a % of price: total tax 35.0% 2022 up 74.2% 145th Taxes as a % of price: value added tax 9.1% 2022 up 39.0% 132nd Taxes as a % of price: ad valorem excise 0.0% 2022 down 100.0% 106th Taxes as a % of price: specific excise 24.5% 2022 — 90th Taxes as a % of price: import duties 1.2% 2022 down 21.9% 32nd Taxes as a % of price: other taxes 0.1% 2022 down 25.0% 56th Vitamin A supplementation coverage rate 14.0% 2023 down 84.1% 49th Inflation-adjusted prices for most sold brand of cigarettes: Price in 280 2022 up 29.9% 58th Estimated number of children needing antiretroviral therapy based on 3,600 2025 down 29.4% 37th Weight-for-height <-3 SD 0.5148 2019 down 35.6% 65th Prevalence of severe wasting, weight for height 0.5% 2019 down 37.5% 67th Physical activity policies for activie societies 20 2023 down 35.5% 2nd Physical activity policies focused on active systems 10 2023 down 67.7% 101st Midwifery personnel 984 2024 up 138.8% 88th Number of deaths from malaria who 3,563 2024 up 8.1% 26th Death rate from malaria 63.48 2024 down 12.1% 10th Incidence of malaria 172.34 2024 down 40.1% 27th Share of one year olds who received the final dose of pneumococcal vac 80 2024 up 220.0% 103rd Diphtheria tetanus pertussis vaccine vs pneumococcal vaccine coverage 80 2024 up 220.0% 103rd Estimated antiretroviral therapy coverage among children 27 2025 up 237.5% 75th Death rate from poisonings 0.8 2021 down 11.1% 66th ← Previous Page 17 of 21 Next →